FMP

FMP

Enter

NVCT - Nuvectis Pharma, Inc.

Profile of Nuvectis Pharma, Inc.(NVCT), Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicine

About

ceo

Mr. Ron Bentsur M.B.A.

sector

Healthcare

industry

Biotechnology

website

https://www.nuvectis.com

exchange

NASDAQ

Description

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.

CIK

0001875558

ISIN

US67080T1088

CUSIP

67080T108

Address

1 Bridge Plaza

Phone

201 614 3150

Country

US

Employee

13

IPO Date

Feb 4, 2022

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep